Current Therapy for Intermittent Claudication

Overview

Journal Drugs

Specialty Pharmacology

Date 1982 Sep 1

PMID 6215241

Citations 6

Authors

M Verstraete

Affiliations

Soon will be listed here.

Citing Articles

Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Holmes B, Brogden R, Heel R, Speight T, Avery G Drugs. 1984; 27(1):6-44.

PMID: 6141044 DOI: 10.2165/00003495-198427010-00002.

Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.

Clissold S, Lynch S, Sorkin E Drugs. 1987; 33(5):430-60.

PMID: 3297620 DOI: 10.2165/00003495-198733050-00002.

Claudication.

Ruckley V Br Med J (Clin Res Ed). 1986; 292(6526):970-1.

PMID: 3083974 PMC: 1339912. DOI: 10.1136/bmj.292.6526.970.

Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

Cameron H, Waller P, Ramsay L Br J Clin Pharmacol. 1988; 26(5):569-76.

PMID: 3061424 PMC: 1386634. DOI: 10.1111/j.1365-2125.1988.tb05297.x.

Pentoxifylline in arterial disease of the legs.

Verhaeghe R, Verstraete M Eur J Clin Pharmacol. 1991; 41(6):507-9.

PMID: 1815961 DOI: 10.1007/BF00314975.

References

Waibel P, Wolff G . The collateral circulation in occlusions of the femoral artery: an experimental study. Surgery. 1966; 60(4):912-8. View

ENGER S, Herbjornsen K, Erikssen J, Fretland A . High density lipoproteins (HDL) and physical activity: the influence of physical exercise, age and smoking on HDL-cholesterol and the HDL-/total cholesterol ratio. Scand J Clin Lab Invest. 1977; 37(3):251-5. DOI: 10.3109/00365517709091490. View

Ehringer H, Dudczak E, Lechner K, Widhalm F . [Therapeutic defibrination using snake venom (Arvin) in arterial circulation disorders]. Verh Dtsch Ges Inn Med. 1972; 78:624-7. View

Verhaeghe R, Van Hoof A, Beyens G . Controlled trial of suloctidil in intermittent claudication. J Cardiovasc Pharmacol. 1981; 3(2):279-86. DOI: 10.1097/00005344-198103000-00006. View

Dahllof A, Bjorntorp P, Holm J, Schersten T . Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency. Eur J Clin Invest. 1974; 4(1):9-15. DOI: 10.1111/j.1365-2362.1974.tb00365.x. View

COFFMAN J . Vasodilator drugs in peripheral vascular disease. Am J Hosp Pharm. 1975; 32(12):1276-81. View

Skinner J, Strandness Jr D . Exercise and intermittent claudication.II. Effect of physical training. Circulation. 1967; 36(1):23-9. DOI: 10.1161/01.cir.36.1.23. View

Jonason T, Jonzon B, Ringqvist I . Effect of physical training on different categories of patients with intermittent claudication. Acta Med Scand. 1979; 206(4):253-8. DOI: 10.1111/j.0954-6820.1979.tb13506.x. View

Martin M . Thrombolytic therapy is arterial thromboembolism. Prog Cardiovasc Dis. 1979; 21(5):351-74. DOI: 10.1016/0033-0620(79)90008-2. View

10.

Malone J, Moore W, Goldstone J . The natural history of bilateral aortofemoral bypass grafts for ischemia of the lower extremities. Arch Surg. 1975; 110(11):1300-6. DOI: 10.1001/archsurg.1975.01360170040005. View

11.

Postlethwaite J, Dormandy J . Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate. Ann Surg. 1975; 181(6):799-802. PMC: 1343897. DOI: 10.1097/00000658-197506000-00006. View

12.

Barndt Jr R, Blankenhorn D, Crawford D, Brooks S . Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients. Ann Intern Med. 1977; 86(2):139-46. DOI: 10.7326/0003-4819-86-2-139. View

13.

. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators. Lancet. 1980; 2(8191):379-85. View

14.

Dormandy J, Hoare E, Colley J, Arrowsmith D, Dormandy T . Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J. 1973; 4(5892):576-81. PMC: 1587739. DOI: 10.1136/bmj.4.5892.576. View

15.

Oliver M . Serum cholesterol--the knave of hearts and the joker. Lancet. 1981; 2(8255):1090-5. DOI: 10.1016/s0140-6736(81)91286-1. View

16.

Yates C, Berent A, Andrews V, Dormandy J . Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication. Lancet. 1979; 2(8135):166-8. DOI: 10.1016/s0140-6736(79)91433-8. View

17.

Hughson W, Mann J, Garrod A . Intermittent claudication: prevalence and risk factors. Br Med J. 1978; 1(6124):1379-81. PMC: 1604804. DOI: 10.1136/bmj.1.6124.1379. View

18.

. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. Br Heart J. 1978; 40(10):1069-118. PMC: 483536. DOI: 10.1136/hrt.40.10.1069. View

19.

Nevelsteen A, Suy R, Daenen W, Boel A, Stalpaert G . Aortofemoral grafting: factors influencing late results. Surgery. 1980; 88(5):642-53. View

20.

LARSEN O, Lassen N . Effect of daily muscular exercise in patients with intermittent claudication. Lancet. 1966; 2(7473):1093-6. DOI: 10.1016/s0140-6736(66)92191-x. View